News
)
28 September 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
An article featured by Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, has just been published by European Pharmaceutical Manufacturer.
Read more)
14 September 2023
The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde
The Medicine Maker has published an opinion article after interviewing Natalia Elizalde, VIVEbiotech´s Chief Business Development Officer.
Read more)
24 August 2023
VIVEbiotech will lead a session with speakers from top international companies during upcoming Biospain
Biospain is a biotechnology congress organized by AseBio - Asociación Española de Empresas Biotecnológicas and is held every two years in a...
Read more)
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with...
Read more)
17 July 2023
VIVEbiotech participates in the XVI Annual Biotechnology Congress
Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023)...
Read more)
11 July 2023
VIVEbiotech contributes to accelerate the development of muscular dystrophies through the European MAGIC project
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international...
Read more)
19 June 2023
VIVEbiotech interview on C> manufacturing trends at Drug Discovery World
VIVEbiotech participated in the ISCT, International Society for Cell & Gene Therapy´s (ISCT) Annual Meeting took place three weeks ago in beautiful Paris.
Read more)
13 June 2023
Gurutz Linazasoro, CEO of VIVEbiotech, participates in the Foro de Biociencia
Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled "Boosting science and research of high quality and impact" at the...
Read more)
4 June 2023
VIVEbiotech has successfully participated in 5 international congresses in the first half of the year
VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.
Read more)
18 May 2023
Article in RegMedNet about lentiviral vectors development and manufacturing challenges
Natalia Elizalde was interviewed at the Phacilitate's Advanced Therapies Week that took place in Miami in January this year.
Read moreDestacadas
28 September 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
14 September 2023
The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde
24 August 2023
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
11 July 2023
4 June 2023